Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0006618309
Wed, 17.05.2023
MEDIQON Group AG
Today, MEDIQON Group AG published its Annual Report for the 2022 financial year.
The entire Annual Report 2022 is available at the following Website:https://www.mediqon-group.de/veroeffentlichungen/annual-reports/
17.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
Wed, 17.05.2023
MEDIQON Group AG
Today, MEDIQON Group AG published its Annual Report for the 2022 financial year.
The entire Annual Report 2022 is available at the following Website:https://www.mediqon-group.de/veroeffentlichungen/annual-reports/
17.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
Fri, 14.04.2023
MEDIQON Group AG
In the 2022 fiscal year, the growth of the group continued again. The platforms belonging to the group have acquired majority stakes in eight additional operating companies. At the end of 2022, the group encompassed a total of 26 operating companies, two of which were minority holdings.
Furthermore, the company’s equity base doubled in the 2022 fi [ … ]
Fri, 14.04.2023
MEDIQON Group AG
In the 2022 fiscal year, the growth of the group continued again. The platforms belonging to the group have acquired majority stakes in eight additional operating companies. At the end of 2022, the group encompassed a total of 26 operating companies, two of which were minority holdings.
Furthermore, the company’s equity base doubled in the 2022 fi [ … ]
Thu, 16.02.2023
MEDIQON Group AG
MEDIQON Group AG: Executive Board contract of Jan-Hendrik Mohr extended
Yesterday, the company's Supervisory Board unanimously extended the contract of CEO Jan-Hendrik Mohr until December 31, 2027.
Supervisory Board Chairman Dr. Mathias Saggau commented:
"We are happy that Jan wants to continue to drive the growth of MEDIQON Group AG and committed [ … ]
Thu, 16.02.2023
MEDIQON Group AG
MEDIQON Group AG: Executive Board contract of Jan-Hendrik Mohr extended
Yesterday, the company's Supervisory Board unanimously extended the contract of CEO Jan-Hendrik Mohr until December 31, 2027.
Supervisory Board Chairman Dr. Mathias Saggau commented:
"We are happy that Jan wants to continue to drive the growth of MEDIQON Group AG and committed [ … ]
Tue, 13.12.2022
MEDIQON Group AG
MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth
As announced in the ad-hoc release of December 13, 2022, MEDIQON Group AG has successfully completed a capital increase.
The company raised EUR 15.5 million in equity by issuing 1,067,267 shares. The shares were subscribed by new shareholders as well as our long-term anchor investors.
[ … ]
Tue, 13.12.2022
MEDIQON Group AG
MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth
As announced in the ad-hoc release of December 13, 2022, MEDIQON Group AG has successfully completed a capital increase.
The company raised EUR 15.5 million in equity by issuing 1,067,267 shares. The shares were subscribed by new shareholders as well as our long-term anchor investors.
[ … ]
Tue, 13.12.2022
MEDIQON Group AG
The private placement of the capital increase resolved on December 12, 2022, excluding subscription rights by issuing new shares was successfully completed in the amount of 1,067,267 new shares. The increase is equivalent to c. 7.1% of the company’s existing share capital. The subscription price was EUR 14.50 per new share, resulting in gross proc [ … ]
Tue, 13.12.2022
MEDIQON Group AG
The private placement of the capital increase resolved on December 12, 2022, excluding subscription rights by issuing new shares was successfully completed in the amount of 1,067,267 new shares. The increase is equivalent to c. 7.1% of the company’s existing share capital. The subscription price was EUR 14.50 per new share, resulting in gross proc [ … ]